Loading company…
ID 405089522 · FY 2020–2024 · 5 years
ძირითად საქმიანობას წარმოადგენს ფარმაცევტული და პარაფარმაციის პროდუქტების იმპორტ-ექსპორტი და საბითუმო რეალიზაცია.
Bars are revenue on the left axis; lines are EBITDA and net margin on the right.
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|---|---|
| Total Current Assets | 1,051 | 2,348 | 4,125 | 4,325 | 5,556 | +51.6% |
| Total Non-Current Assets | 2 | 2 | 61 | 682 | 663 | nmf |
| TOTAL ASSETS | 1,053 | 2,350 | 4,185 | 5,008 | 6,219 | +55.9% |
| Total Current Liabilities | 194 | 242 | 290 | 756 | 347 | +15.7% |
| Total Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | |
| TOTAL LIABILITIES | 194 | 242 | 290 | 756 | 347 | +15.7% |
| Total Equity | 860 | 2,108 | 3,895 | 4,252 | 5,871 | +61.7% |
| Balance Check (Assets - L&E) | 0 | 0 | 0 | 0 | 0 | |
| Debt analysis | ||||||
| Total Debt | 0 | 0 | 2 | 1 | 68 | +524.3% |
| Cash & Equivalents | 57 | 1 | 53 | 122 | 1,817 | +138.1% |
| Net Debt | -57 | -1 | -51 | -121 | -1,749 | +135.8% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Companies sharing this sub-sector, ranked by how close their latest revenue is to this one — not a curated comp set.
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
Ownership & directors from companyinfo.ge (public corporate registry).